SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-020819
Filing Date
2018-11-14
Accepted
2018-11-14 16:10:11
Documents
49
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q innv20180930_10q.htm 10-Q 792011
2 EXHIBIT 31.1 ex_129695.htm EX-31.1 13446
3 EXHIBIT 31.2 ex_129696.htm EX-31.2 13643
4 EXHIBIT 32.1 ex_129697.htm EX-32.1 5188
  Complete submission text file 0001437749-18-020819.txt   4778698

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT innv-20180930.xml EX-101.INS 902066
6 XBRL TAXONOMY EXTENSION SCHEMA innv-20180930.xsd EX-101.SCH 49116
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE innv-20180930_cal.xml EX-101.CAL 43268
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE innv-20180930_def.xml EX-101.DEF 347171
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE innv-20180930_lab.xml EX-101.LAB 316372
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE innv-20180930_pre.xml EX-101.PRE 364115
Mailing Address 8845 REHCO ROAD SAN DIEGO CA 92121
Business Address 8845 REHCO ROAD SAN DIEGO CA 92121 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

IRS No.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52991 | Film No.: 181183787
SIC: 2834 Pharmaceutical Preparations